Welcome to the Trial Talks podcast – a thought-provoking series surrounding clinical trial research. We’ll be exploring current and future trends of the ever-changing clinical trial landscape as we discuss a variety of topics including virtual trials, patient centricity, novel and unique research, pandemic impact, and more. Join us and our expert guests on a journey through the evolution of clinical trials.
Achieving Patient Centricity by Removing Barriers in the Clinical Trial Process
Constantly changing regulations and a multitude of new endpoints continue to keep clinical researchers on their toes. While these regulations and endpoints are designed to keep patients safe, they often create unintended barriers that keep patients out of clinical trials. In this episode, we discuss with Kafayat Babajide, Director of Patient Insights & Experience with Johnson and Johnson, the ways in which a patient-centric approach can remove controllable barriers from the clinical trial process and strengthen your patient engagement.
Patient Advocacy and Oncology: How A Community Cancer Network is Making a Difference
Approximately 39.5% of all men and women will be diagnosed with cancer at some point during their lifetimes, and yet only 8% of oncology patients participate in clinical trials. Many industry leaders think that a greater focus on patient advocacy could be the missing link.In this episode, Rose Gerber, Director of Patient Advocacy and Education at the Community Oncology Alliance – once a patient herself and now a dedicated advocate – will share her story and discuss how patient advocacy is helping to increase patient enrollment in clinical trials across every therapeutic area.
EDC and RTSM: A Winning Combination
Reducing the number of vendors you interact with allows you to not only achieve higher quality data, you can also spend more time focusing on what matters- the patients. Our fully integrated RTSM and EDC allows you to spend more time focused on your data and less on outside programmers and vendors. In this episode we will explore the value of a combined solution and what you can expect in return.
The Long Road to Achieving Health Equity
It’s no secret that the United States has documented disparities in morbidity and mortality rates among racial/ethnic minority groups and those of lower socioeconomic status. More recently we’ve seen a disproportionate amount of African Americans affected by COVID-19, but they have been underrepresented in clinical research. In this podcast we are joined by Kimberly Richardson, Patient Advocate and Cancer Survivor, to discuss how we can work towards achieving health equity in the United States, what steps can be taken today, and the impact this would have on clinical research and underserved communities.
Why Patient Advocacy Has Become Critical to Clinical Trials
Patients are no longer passive research subjects, but rather being integrated into the research process from the start. Patient advocates help with such integrations, from protocol design through to clinical trial findings. It has been proven that designing clinical trials to meet the patient needs facilitates better patient adherence and reduces patient drop out rates.
But more importantly, advocating for a patient is advocating for a human being, not a test subject. As clinical research evolves more emphasis has been placed on patient experience, rather than just data points. Listen to discover how a patient advocate, Susan Stein, MPH, advances patient care, brings the patient voice and insights into discussions and organizational decision making.
Why Use an EDC for Animal Health Studies?
ClinData is a leading South African CRO focused on Animal Health studies, they recently eradicated paper from 21 studies with plans to move more to electronic data capture going forward. In this podcast we’ll discuss how ClinData succeeded in making the switch from paper to EDC and the benefits of this change for animal health studies.
Gives me hope!
Great podcast that gives me hope for the future of research, medicine, and humanity!